| Clinical data | |
|---|---|
| Other names | Lu-29-252; LU-29252; LU29252; Lu 29–252 |
| Drug class | Sigmaσ2 receptorligand |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| PubChem SID | |
| Chemical and physical data | |
| Formula | C28H36N2O2 |
| Molar mass | 432.608 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Lu 29-252 is aselectivesigmaσ2 receptorligand which was under development for the treatment ofanxiety disorders but was never marketed.[1][2][3][4][5] It reached thepreclinical stage of development prior to the discontinuation of its development.[1] The drug was under development byLundbeck.[1]
This article about ananxiolytic is astub. You can help Wikipedia byexpanding it. |